How much funding has Cadence Pharmaceuticals raised?

Cadence Pharmaceuticals has raised $86.6M in total funding, most recently a Series A round.

Who are Cadence Pharmaceuticals's investors?

Cadence Pharmaceuticals's investors include Venrock, Frazier Healthcare, Domain Associates, Jerel Davis, New Enterprise Associates.

Where is Cadence Pharmaceuticals headquartered?

Cadence Pharmaceuticals is headquartered in San Diego, California, United States.

What industry is Cadence Pharmaceuticals in?

Cadence Pharmaceuticals operates in Biopharmaceutical, Hospital.

How many employees does Cadence Pharmaceuticals have?

Cadence Pharmaceuticals has 51-200 employees.

Cadence Pharmaceuticals

Closed

San Diego, United States · $86.6M raised

Biopharmaceutical

Hospital

Headquarters: San Diego, California
Employees: 51–200
Business Model: B2B
Website: cadencepharm.com

Total Funding: $86.6M
Last Round: $86.6M Series AFeb 2009
Rounds: 1

About

Cadence Pharmaceuticals was a San Diego-based specialty pharmaceutical company focused on developing and commercializing products for use in the hospital setting, primarily targeting acute pain management. The company's lead product was Ofirmev (IV acetaminophen). Cadence raised approximately $197 million in funding before being acquired by Mallinckrodt PLC in 2014 for approximately $1.3 billion.

Summary

Cadence Pharmaceuticals is a Biopharmaceutical company based in San Diego, United States. It has raised $86.6M in total across 1 round, most recently a $86.6M Series A round in Feb 2009. Investors include Venrock, Frazier Healthcare and Domain Associates.